🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT07513987
Starting soon Not applicable

IMPACT: Immune and Musculoskeletal Physiological Adaptations to Combined Exercise Training & Nutrition

NCT07513987 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-05-01
Last updated
2026-04-07

Condition(s) studied

Overweight (BMI > 25)Males and Females

Investigational drug(s) / intervention(s)

MilkGreek YogurtExercise training

Milk: 2 servings of 1% MF milk (1 serving = 250 mL) on non-training days and 3 servings on training days, integrated into habitual diet.

Greek Yogurt: 2 servings of plain or flavoured GY (1 serving = 175 g) on non-training days, and 3 servings of GY on training days, integrated into your habitual diet.

Exercise training: 12-week structured exercise training program. Exercise sessions will take place three times per week and will last approximately 60 minutes per session. Sessions will be conducted at York University in the Exercise Research Lab. Each session will be facilitated by a certified personal trainer and/or kinesiology student

Study summary

The purpose of this study is to determine whether 12 weeks of exercise training combined with dairy consumption influences inflammation and immune responses in adults with overweight, compared to exercise training alone.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Between the ages of 18 and 50 years * Overweight BMI (25.0-29.9) kg/m2 * 'Overweight' body fat percentage (males: ≤30%; females: ≤42%) * Low to moderately physically active (0-2 times/week) * Habitual low dairy consumption (≤ 1 serving/day, assessed via baseline food record) Exclusion Criteria: * Peri- or postmenopausal status (female) * Dairy protein allergy or lactose intolerance * Use of vitamin D and/or calcium supplements * Any musculoskeletal, autoimmune, or inflammatory conditions * Use of medication related to a chronic condition

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
York University Toronto Ontario

More York University trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07513987 on ClinicalTrials.gov ↗ ← All trials in Canada